Abstract:The aim of the following review is to shed light on the putative role of regulatory B cells (Bregs) in various human diseases and highlight their potential prognostic and therapeutic relevance in humans. Regulatory B cells are a heterogeneous group of B lymphocytes capable of suppressing inflammatory immune reactions. In this way, Bregs contribute to the maintenance of tolerance and immune homeostasis by limiting ongoing immune reactions temporally and spatially. Bregs play an important role in attenuating pathological inflammatory reactions that can be associated with transplant rejection, graft-versus-host disease, autoimmune diseases and allergies but also with infectious, neoplastic and metabolic diseases. Early studies of Bregs identified IL-10 as an important functional molecule, so the IL-10-secreting murine B10 cell is still considered a prototype Breg, and IL-10 has long been central to the search for human Breg equivalents. However, over the past two decades, other molecules that may contribute to the immunosuppressive function of Bregs have been discovered, some of which are only present in human Bregs. This expanded arsenal includes several anti-inflammatory cytokines, such as IL-35 and TGF-β, but also enzymes such as CD39/CD73, granzyme B and IDO as well as cell surface proteins including PD-L1, CD1d and CD25. In summary, the present review illustrates in a concise and comprehensive manner that although human Bregs share common functional immunosuppressive features leading to a prominent role in various human immunpathologies, they are composed of a pool of different B cell types with rather heterogeneous phenotypic and transcriptional properties.

Regulatory B Cells and Autoimmune Diseases

Regulatory B cells in autoimmune diseases

Tgf-Beta-Induced Regulatory T Cells Directly Suppress B Cell Responses Through A Noncytotoxic Mechanism

Regulatory B cells in autoimmune diseases and mucosal immune homeostasis

Regulatory B cells:research advances

Regulatory B cells, A to Z

Regulatory B Cells and Its Role in Central Nervous System Inflammatory Demyelinating Diseases

Mechanisms of Regulatory B cell Function in Autoimmune and Inflammatory Diseases beyond IL-10

B Cell Activation and Autoantibody Production in Autoimmune Diseases.

Immunosuppressive Mechanisms of Regulatory B Cells

B cell signaling and autoimmune diseases: CD19/CD22 loop as a B cell signaling device to regulate the balance of autoimmunity

Il-10-Independent Regulatory B-Cell Subsets and Mechanisms of Action

The Molecular Basis Of Immune Regulation In Autoimmunity

Epigenetic Regulation of B Cells and Its Role in Autoimmune Pathogenesis

Regulatory B cells and T cell Regulation in Cancer

Regulatory B Cells—Immunopathological and Prognostic Potential in Humans

HSP70, a Novel Regulatory Molecule in B Cell-Mediated Suppression of Autoimmune Diseases.

T Follicular Helper Cells and Regulatory B Cells Dynamics in Systemic Lupus Erythematosus.

Engagement of B7 on Effector T Cells by Regulatory T Cells Prevents Autoimmune Disease.

B Cells Control Lupus Autoimmunity by Inhibiting Th17 and Promoting Th22 Cells

The Potential Role of Regulatory B Cells in Idiopathic Membranous Nephropathy